These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1300969)

  • 21. Maple syrup urine disease-treatment and outcome in patients of Turkish descent in Germany.
    Simon E; Wendel U; Schadewaldt P
    Turk J Pediatr; 2005; 47(1):8-13. PubMed ID: 15884622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
    Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
    Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical consequences of disorders in the intermediate metabolism of branched chain amino acids (valine, leucine and isoleucine).
    Mogoş T; Cheţa CP; Mincu IT
    Rom J Intern Med; 1994; 32(1):57-61. PubMed ID: 8081313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definition of the mutation responsible for maple syrup urine disease in Poll Shorthorns and genotyping Poll Shorthorns and Poll Herefords for maple syrup urine disease alleles.
    Dennis JA; Healy PJ
    Res Vet Sci; 1999 Aug; 67(1):1-6. PubMed ID: 10425233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous venovenous hemofiltration in the management of acute decompensation in inborn errors of metabolism.
    Thompson GN; Butt WW; Shann FA; Kirby DM; Henning RD; Howells DW; Osborne A
    J Pediatr; 1991 Jun; 118(6):879-84. PubMed ID: 2040923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Removal of amino acids by continuous hemofiltration and hemodiafiltration].
    Gouyon JB; Françoise M; Desgres J; Petion AM; Sandre D
    Arch Pediatr; 1994 May; 1(5):501-4. PubMed ID: 7951837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posttraumatic dental implant placement in a patient with maple syrup urine disease.
    Oelgiesser D; Levin L; Elpeleg O; Schwartz-Arad D
    Implant Dent; 2006 Jun; 15(2):143-7. PubMed ID: 16766896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous venovenous haemodiafiltration in the acute phase of neonatal maple syrup urine disease.
    Jouvet P; Poggi F; Rabier D; Michel JL; Hubert P; Sposito M; Saudubray JM; Man NK
    J Inherit Metab Dis; 1997 Aug; 20(4):463-72. PubMed ID: 9266382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maple syrup urine disease. Two cases in Israel.
    Chemke J; Levin S
    Isr J Med Sci; 1975 Aug; 11(8):809-16. PubMed ID: 1165176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Leucinosis: study of a case].
    Moura-Ribeiro MV; Funayama CA
    Arq Neuropsiquiatr; 1985 Dec; 43(4):403-6. PubMed ID: 3833142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic modeling of plasma leucine levels during continuous venovenous extracorporeal removal therapy in neonates with maple syrup urine disease.
    Jouvet P; Hubert P; Saudubray JM; Rabier D; Man NK
    Pediatr Res; 2005 Aug; 58(2):278-82. PubMed ID: 16085796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neonatal leucinosis with favourable course. Therapeutic problems].
    Astruc J; Froye E; Luciani JM; Bellet H; Magnan de Bornier P; Brunel D
    Ann Pediatr (Paris); 1977 Sep; 24(8-9):605-10. PubMed ID: 16211914
    [No Abstract]   [Full Text] [Related]  

  • 34. Maple syrup urine disease (MSUD)--clinical profile of 47 Filipino patients.
    Lee JY; Chiong MA; Estrada SC; Cutiongco-De la Paz EM; Silao CL; Padilla CD
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S281-5. PubMed ID: 18989748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of a Woman With Maple Syrup Urine Disease During Pregnancy, Delivery, and Lactation.
    Wessel AE; Mogensen KM; Rohr F; Erick M; Neilan EG; Chopra S; Levy HL; Gray KJ; Wilkins-Haug L; Berry GT
    JPEN J Parenter Enteral Nutr; 2015 Sep; 39(7):875-9. PubMed ID: 24618664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children].
    Kowalik A; Narojek L; Sykut-Cegielska J
    Rocz Panstw Zakl Hig; 2007; 58(1):95-101. PubMed ID: 17711097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous venovenous haemofiltration in the acute treatment of inborn errors of metabolism.
    Falk MC; Knight JF; Roy LP; Wilcken B; Schell DN; O'Connell AJ; Gillis J
    Pediatr Nephrol; 1994 Jun; 8(3):330-3. PubMed ID: 7917860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential response to renal replacement therapy in neonatal-onset inborn errors of metabolism.
    Porta F; Peruzzi L; Bonaudo R; Pieretti S; Busso M; Cocchi E; Conio A; Pagliardini V; Spada M
    Nephrology (Carlton); 2018 Oct; 23(10):957-961. PubMed ID: 29888426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maple syrup urine disease: treatment of the acutely ill newborn.
    Hammersen G; Wille L; Schmidt H; Lutz P; Bickel H
    Eur J Pediatr; 1978 Oct; 129(3):157-65. PubMed ID: 699921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [3 patients with maple syrup urine disease].
    Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
    An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.